Theodore L. Harris - 15 Sep 2022 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
Chairman, President & CEO, Director
Signature
/s/ Travis Larsen, Attorney in Fact for Theodore L. Harris
Issuer symbol
BCPC
Transactions as of
15 Sep 2022
Net transactions value
$0
Form type
4
Filing time
19 Sep 2022, 16:16:49 UTC
Previous filing
16 Feb 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option (Right to Buy) Award $0 +130,000 $0.000000 130,000 15 Sep 2022 Common Stock 130,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options grant is structured in four tranches with increasing exercise prices as follows: (a) 25% at fair market value as of grant date of $125.71; (b) 25% at $125.71 plus 10% premium; (c) 25% at $125.71 plus 15% premium; and (d) 25% at $125.71 plus 20% premium.
F2 The stock options vest over a five-year period with: (a) 25% vesting on 9/15/2025; (b) 25% vesting on 9/15/2026; and (c) 50% vesting on 9/15/2027.